PAN Foundation Launches COVID-19 Treatment and Prevention Fund to Help At-Risk Medicare Beneficiaries Pay for Treatment, Groceries and Other Critical Services

PAN Foundation, is an independent charitable organization dedicated to helping underinsured patients access critical medical care. Today they announced that it will offer financial assistance to Americans with existing medical conditions who have COVID-19 or are quarantined because of the virus.

Through this comprehensive fund, PAN will provide a $300 grant to qualifying Medicare beneficiaries with cancer, chronic or rare diseases who have also been diagnosed with COVID-19 or directed to self-quarantine by their healthcare provider or a government agency. Grant recipients can use the funds for treatment co-pays, prescription and over-the-counter medications, medical supplies and other important expenses related to COVID-19 prevention and treatment, including transportation to medical appointments and groceries, meals and food delivery services.

“The COVID-19 pandemic is a stark reminder of the importance of our mission to ensure that every American can afford the healthcare they need. While we don’t know the full impact of this outbreak, we’re dedicated to doing everything we can to protect and support the most vulnerable members of our society,” said PAN President and CEO Daniel J. Klein. “As Medicare beneficiaries and people with serious health conditions learn to cope with this rapidly evolving situation, we’re committed to providing assistance to help those who need it most so they can focus on getting better and worry less about the cost of care.”

The results of a recent poll by the Commonwealth Foundation highlight the collective worry of Americans about their ability to afford medical treatment: 68 percent of adults said that the out-of-pocket costs they might have to pay would be very or somewhat important in their decision to get treatment if they had symptoms of the coronavirus.

The COVID-19 Treatment and Prevention Fund is currently open for applicants who have annual household incomes up to 400 percent of the federal poverty level. Eligible patients can learn more about the fund on our website or by calling PAN at 1-866-316-7263 from Monday through Friday, 9 a.m. to 7 p.m. ET.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version